BIIB
Biogen Inc
Price:  
219.21 
USD
Volume:  
1,726,114.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Biogen Relative Valuation

101.3%
Upside

As of 2024-02-21, the Relative Valuation of Biogen Inc (BIIB) is 441.32 USD. This relative valuation is based on P/E multiples. With the latest stock price at 219.21 USD, the upside of Biogen Inc based on Relative Valuation is 101.3%.

The range of the Relative Valuation is 328.88 - 583.41 USD.

Range Selected
Trailing P/E multiples 32.6x - 49.5x 34.7x
Forward P/E multiples 25.4x - 28.9x 26.4x
Fair Price 328.88 - 583.41 441.32
Upside 50.0% - 166.1% 101.3%
219.21 USD
Stock Price
441.32 USD
Fair Price

Biogen Relative Valuation - Historical P/E Data

Date P/E
2024-02-21 21.81
2024-02-20 21.73
2024-02-16 21.72
2024-02-15 22.14
2024-02-14 21.88
2024-02-13 22.47
2024-02-12 24.26
2024-02-09 23.89
2024-02-08 23.82
2024-02-07 23.84
2024-02-06 24.34
2024-02-05 23.97
2024-02-02 24.16
2024-02-01 24.57
2024-01-31 24.45
2024-01-30 24.49
2024-01-29 24.54
2024-01-26 24.27
2024-01-25 24.41
2024-01-24 24.50
2024-01-23 24.95
2024-01-22 24.61
2024-01-19 24.78
2024-01-18 24.48
2024-01-17 24.31
2024-01-16 24.40
2024-01-12 24.59
2024-01-11 24.50
2024-01-10 25.20
2024-01-09 25.36
2024-01-08 25.57
2024-01-05 25.56
2024-01-04 25.80
2024-01-03 26.11
2024-01-02 26.54
2023-12-29 25.65
2023-12-28 25.83
2023-12-27 25.96
2023-12-26 25.84
2023-12-22 25.57
2023-12-21 25.16
2023-12-20 24.60
2023-12-19 24.95
2023-12-18 24.81
2023-12-15 24.60
2023-12-14 25.43
2023-12-13 25.33
2023-12-12 24.69
2023-12-11 24.40
2023-12-08 23.72